| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 253 | 1.843 | 6.118 | 3.798 | 81.478 | 144.919 |
| Total Income - EUR | - | - | - | - | 253 | 1.843 | 6.118 | 3.798 | 81.478 | 144.919 |
| Total Expenses - EUR | - | - | - | - | 294 | 1.628 | 4.979 | 2.998 | 77.765 | 121.344 |
| Gross Profit/Loss - EUR | - | - | - | - | -41 | 215 | 1.140 | 799 | 3.713 | 23.576 |
| Net Profit/Loss - EUR | - | - | - | - | -49 | 165 | 978 | 702 | 2.935 | 20.369 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Fitofarm Terrasano S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 68 | 33 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 38 | 544 | 1.487 | 18.766 | 38.529 | 75.746 |
| Inventories | - | - | - | - | 0 | 537 | 728 | 13.450 | 31.281 | 53.719 |
| Receivables | - | - | - | - | 0 | 0 | 9 | 987 | 2.276 | 5.544 |
| Cash | - | - | - | - | 38 | 7 | 749 | 4.329 | 4.972 | 16.483 |
| Shareholders Funds | - | - | - | - | -7 | 159 | 1.133 | 1.839 | 4.068 | 24.415 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 113 | 419 | 354 | 16.928 | 34.461 | 51.331 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Fitofarm Terrasano S.r.l.